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Synergy between HIV-1 Tat and 
adenovirus El A is principally due to 
stabilization of transcriptional elongation 
Michael F. Laspia/ Andrew P. Rice, and Michael B. Mathews 
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 USA 
We studied the combined effects of Tat and general trans-activators, such as ElA and phorbol esters, on human 
immunodeficiency virus-1 (HIV-1) gene expression. Interaction between these two types of trans-activators 
may be involved in the transition from transcriptional quiesence during viral latency to active gene expression 
during productive infection. ElA cooperated with Tat to produce a fourfold greater increase in accumulation of 
full-length, cytoplasmic HIV-1-directed RNA than is expected if they were acting additively to increase RNA 
accumulation. Similarily, phorbol 12-myristate 13-acetate (PMA) also cooperated with Tat to elevate HIV RNA 
levels synergistically. Analysis of transcription rates across the HIV-1-directed transcription unit indicated, 
unexpectedly, that synergy between Tat and ElA could not be accounted for by increased promoter proximal 
transcription rates that were merely additive. However, Tat and ElA produced a greater than additive increase 
in transcription rates in the 3' end of the gene. These findings imply that synergy between Tat and ElA (or 
other general transcriptional activators) is due principally to stabilization of transcriptional elongation. 
Furthermore, the observation that Tat elicits only a small increase in promoter proximal transcription in the 
presence of ElA suggests that the magnitude of the effect of Tat on initiation is decreased when the basal level 
of transcription is increased. These findings underscore the importance of the ability of Tat to stabilize 
elongation, as well as to stimulate initiation, in an HIV-1-directed transcription unit. 
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The tat gene of human immunodeficiency virus-1 
(HIV-1) encodes a potent, essential trans-activator that 
greatly stimulates the expression of genes linked to the 
viral long terminal repeat (LTR) (Arya et al. 1985; So-
droski et al. 1985b). A sequence called trans-activation 
response (TAR) (Rosen et al. 1985), located downstream 
of the site of transcription initiation, minimally from 
nucleotides -1-14 to +44 relative to the transcription 
start (Hauber and CuUen 1988; Jakobovits et al. 1988), is 
required for Tat trans-activation of LTR-directed gene 
expression. 
The RNA leader made by transcription of the TAR el-
ement is capable of forming an imperfect stem-loop 
structure (Muesing et al. 1987), and mutations that 
disrupt this structure greatly reduce trans-activation by 
Tat (Feng and Holland 1988). The introduction of 
flanking sequences that prevent the formation of TAR 
RNA secondary structure also prevents trans-activation 
(Berkhout et al. 1989), suggesting that Tat interacts with 
TAR at the RNA level. In support of this conclusion, a 
fusion protein in which Tat is linked to the RNA-
binding domain of the Rev protein is capable of trans-ac-
tivating a modified HIV-1 promoter where TAR has been 
'Corresponding author. 
replaced by the sequences that form the RNA-binding 
site for Rev (Southgate et al. 1990). This result indicates 
that the primary function of TAR is to provide a binding 
site for Tat at the HIV-1 promoter. Tat binds to the stem 
of TAR RNA in vitro (Dingwall et al. 1989), and muta-
tions in the upper portion of the stem that prevent 
binding also reduce trans-activation greatly in vivo (Roy 
et al. 1990). Therefore, at least one component of Tat 
trans-activation requires that Tat bind to nascent TAR 
RNA. Cellular proteins are also likely to be involved in 
the interaction between Tat and TAR (Marciniak et al. 
1990) because mutations in the loop region that do not 
affect Tat binding greatly reduce trans-activation (Roy et 
al. 1990; Weeks et al. 1990). 
Regulation of HIV-1 gene expression by Tat has been 
proposed to occur at a number of different levels (for re-
view, see Varmus 1988; Sharp and Marciniak 1989; Pav-
lakis and Felber 1990). Tat produces a large stimulation 
of HIV-1-promoted RNA levels (CuUen 1986; Peterlin et 
al. 1986; Wright et al. 1986; Hauber et al. 1987; Muesing 
et al. 1987; Rice and Mathews 1988a) so the predomi-
nant mode of regulation appears to be transcriptional 
(Hauber et al. 1987; Kao et al. 1987; Jakobovits et al. 
1988; Jeang et al. 1988; Rice and Mathews 1988a; Sadaie 
et al. 1988; Laspia et al. 1989), but evidence for post-
transcriptional regulation also exists (Cullen 1986; Fein-
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berg et al. 1986; Rosen et al. 1986; Wright et al. 1986; 
Braddock et al. 1989, 1990). In a model system con-
sisting of replicating plasmids in COS cells, Kao et al. 
(1987) found that Tat does not increase the initiation of 
transcription but act to stimulate transcriptional elonga-
tion. They concluded that Tat acts as an antiterminator, 
relieving a block to transcriptional elongation occurring 
within the HIV-1 leader. On the other hand, our studies 
indicated that Tat acts through TAR to stimulate tran-
scription in a bimodal manner: It increases transcrip-
tional initiation and also stabilizes transcriptional elon-
gation (Laspia et al. 1989). We compared trans-actiwation 
by Tat to £r^/is-activation by the adenovirus El A protein 
in HeLa cells infected with a recombinant adenovirus 
containing an HIV-1 LTR-promoted reporter gene. In the 
absence of trans-activators, the basal level of HIV-1-di-
rected transcription is low and exhibits a marked po-
larity with RNA polymerase density, declining with in-
creasing distance from the promoter. Tat both increases 
RNA polymerase density in the immediate vicinity of 
the promoter and reduces transcriptional polarity, 
whereas El A increases polymerase density near the pro-
moter without any detectable suppression of polarity. 
The interaction between Tat and other transcriptional 
activators may be involved in the transition from low-
level basal transcription early in infection or during viral 
latency to high-level expression in the active stages of 
viral growth (Cullen and Greene 1989; Pomerantz et al. 
1990). Therefore, we have extended our analysis of 
HIV-1 gene regulation by examining the combined effect 
of Tat and the general transcriptional activator El A on 
LTR-directed gene expression. Together, Tat and El A 
produced a synergistic stimulation of LTR-promoted 
gene expression. The primary basis for the synergy was 
increased transcription in the 3 ' end of the gene, im-
plying that synergy is principally due to reduced elonga-
tional polarity rather than to increased transcriptional 
initiation. Studies with phorbol esters suggest that this 
is a general mechanism. In addition, we found that the 
magnitude of the stimulation of transcription initiation 
by Tat varies as a function of the basal level of transcrip-
tion initiation. This observation may account for the ap-
parent lack of a stimulatory effect of Tat on transcrip-
tional initiation in some systems. 
Results 
Synergistic trans-activation of LTR-promoted gene 
expression 
We examined the interaction between Tat and a general 
transcriptional activator. El A, by analyzing reporter 
gene expression in HeLa cells infected with a recombi-
nant adenovirus. The recombinant adenovirus 
HIV-lCATad contains HIV-1 LTR sequences - 4 5 4 to 
-f 83 fused to the reporter gene chloramphenicol acetyl-
transferase (CAT) and SV40 processing signals (Fig. 2B, 
below; Rice and Mathews 1988a,b). This virus possesses 
the TAR element, including the sequences from -i-14 to 
+ 44 that confer Tat responsivity. In the experiments de-
scribed here. Tat was expressed constitutively in HeLa 
cells from an integrated Tat cDNA under the control of 
the SV40 early promoter [HeLa/tat-, Valerie et al. 1988), 
and El A was supplied by coinfection with phenotypi-
cally wild-type adenovirus (Rice and Mathews 1988b). 
In the experiment shown in Figure 1, Tat and El A in-
dividually stimulated LTR-promoted CAT activity 371-
fold and 21-fold, respectively. In cells that expressed Tat 
and El A simultaneously, however, LTR-directed CAT 
activity was stimulated 1772-fold, which is more than 
four times that expected if they acted additively. There-
fore, these two trans-activators are able to cooperate to 
produce synergistic stimulation of LTR-promoted gene 
expression. 
Synergy in the accumulation of LTR-directed RNA 
To elucidate the nature of this synergy, we first exam-
ined the combined effects of Tat and El A on LTR-pro-
moted RNA levels. Two classes of HIV-1-promoted 
RNA are detected by RNase protection assay (Fig. 2A): a 
full-length poly(A)'' class that protects probe fragments 
of ~83 nucleotides and a short poly(A)~ class that pro-
tects probe fragments of 55 and 59 nucleotides and repre-
sents terminated or processed RNA (Fig. 2B). The pro-
tected species of intermediate lengths have been 
ascribed to partial degradation of full-length RNA in the 
protection assay because they are also observed with 
poly(A)+ RNA (Laspia et al. 1989). 
Quantitation of the 83-nucleotide protected fragment 
indicated that Tat and El A individually stimulated the 
level of full-length transcript 16-fold and 4-fold, respec-
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Figure 1. Expression of CAT in recombinant adenovirus-in-
fected cells. CAT assays were performed on lysates from 
HIV-lCATad-infected HeLa cells (HeLa), HeLa/tat cells (-^Tat), 
HeLa cells coinfected with dl309 (-HEIA), or HeLa/tat cells 
coinfected with di309 (-^Tat +E1A1. HIV-lCATad infections 
were carried out at an moi of 100, and di309 coinfections were 
carried out at an moi of 50. Cells were harvested 24 hr postin-
fection. Stimulation relative to HeLa is shown above each bar. 
The data presented are the average of three experiments. 
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Figure 2. Analysis of HIV-1 LTR-directed cytoplasmic 
RNA levels from recombinant adenovirus-infected cells. 
[A] RNase protection assay of cytoplasmic RNA isolated 
from HIV-lCATad-infected HeLa cells (lane 1), HeLa/tat 
(lane 2), HeLa cells coinfected with di309 (lane 3), or 
HeLa/tat coinfected with dl309 (lane 4). Markers are 
Hpall fragments of pBR322 labeled with ^^P. Infections 
were as in Fig. 1, and cytoplasmic RNA was isolated 24 
hr postinfection. The antisense riboprobe is described in 
B. The faint band in lanes 1-4 below the 110-nucleotide 
marker was present in the tRNA control lane (data not 
shown). Shown are a short exposure [left] and a longer 
exposure [right] of the same gel. (B) Schematic of the re-
combinant adenovirus and antisense riboprobe used in 
the RNase protection assay. HIV-lCATad contains the 
HIV-I LTR sequence -642 to -1-83. The homologous an-
tisense riboprobe was synthesized from pGEM23 linear-
ized with Xbal. Full-length RNA transcripts initiating at 
+ I of the HIV-1 LTR and extending into the CAT gene 
protect an 83-nucleotide fragment of the riboprobe, 
whereas short transcripts (short) initiating at -t-1 and 
ending at -(- 55 or + 59 protect fragments of 55 and 59 
nucleotides, respectively. (C) Relative HIV-1-directed 
RNA levels. Radioactivity was quantified by direct gel 
scanning. The stimulation in the full-length transcripts 
relative to HeLa is depicted. Data are the average of six 
experiments. 
tively (Fig. 2A, lanes 2 and 3; Fig. 2C). Simultaneous ex-
pression of Tat and El A produced a large increase (84-
fold) in the amount of LTR-directed full-length RNA 
(Fig. 2A, lane 4). This increase, again, was over four 
times that predicted if they acted additively (Fig. 2C), 
indicating that Tat and El A cooperate to produce a syn-
ergistic stimulation in the accumulation of full-length 
LTR-promoted RNA. As expected, Tat trans-activation 
and synergy between Tat and El A was abolished by a 
deletion in the TAR region (data not shown). A similar 
synergistic stimulation of LTR-directed CAT enzyme 
and full-length RNA levels was observed as early as 8 hr 
postinfection (data not shown), as well as at the 24-hr 
time point shown. 
Tat produced a slight reduction in the level of short 
transcripts in Figure 2A, although the short transcripts 
remained unchanged in other experiments (Laspia et al. 
1989, and data not shown). As shown previously, ElA 
increased the level of the short transcripts. The simulta-
neous expression of Tat and ElA caused an increase in 
the accumulation of short transcripts, but this increase 
was not synergistic. In the presence of Tat + ElA, the 
level of short transcripts was slightly lower than in the 
presence of ElA alone but higher than in the presence of 
Tat alone. These observations suggest that when Tat 
and El A act in concert, each affects the elevated level of 
transcription produced by the other in a fashion similar 
to their individual effects on basal transcription. There-
fore, it seems that synergy may be due to the combined 
independent actions of Tat and ElA rather than to a 
novel stimulatory mechanism. 
CAT RNA utilization correlates with RNA 
accumulation 
Noting a greater increase in the accumulation of CAT 
GENES & DEVELOPMENT 2399 
 Cold Spring Harbor Laboratory Press on November 3, 2017 - Published by genesdev.cshlp.orgDownloaded from 
Laspia et al. 
activity than in CAT RNA in the presence of Tat, sev-
eral workers have concluded that Tat can stimulate gene 
expression at the post-transcriptional level (for review, 
see Sharp and Marciniak 1989; Pavlakis and Felber 
1990). This idea remains controversial as other workers 
have failed to detect such an effect. Comparison of the 
data presented in Figures 1 and 2C revealed a substan-
tially greater increase in CAT activity than in full-
length CAT RNA in the presence of Tat alone or 
Tat + ElA. This discrepancy was not Tat-specific, how-
ever, as an increase was also seen with ElA alone. Figure 
3 shows how CAT RNA utilization, measured as the 
ratio of CAT enzyme to CAT RNA, varied with the level 
of CAT RNA present in cells expressing either ElA, Tat, 
or Tat -f ElA. RNA utilization increased with in-
creasing RNA level until a plateau was reached. This 
correlation imphes that up to a limit, each RNA mole-
cule gives rise to more CAT enzyme at high RNA con-
centration than at low RNA concentration, regardless of 
the presence or absence of Tat. This interpretation is 
consistent with previous data indicating that Tat has no 
direct effect on CAT RNA translation (Rice and 
Mathews 1988a). Another interpretation, which in our 
view is less likely, is that Tat and ElA act separately to 
increase the utilization of TAR CAT mRNA. While the 
mechanism for the effect is unknown, it could be trans-
lational, perhaps related to the interactions of TAR RNA 
with the protein kinase DAI (Edery et al. 1989; Sen-
Gupta and Silverman 1989; Gunnery et al. 1990; Sen-
Gupta et al. 1990). However, post-translational mecha-
nisms, such as concentration-dependent changes in 
CAT enzyme stability, also cannot be excluded. 
40 60 
RNA Level 
Figure 3. Accumulation of CAT activity at different cyto-
plasmic RNA levels. The efficiency of RNA utiUzation is de-
fined as the ratio of stimulation of CAT activity to the stimula-
tion of full-length RNA level. This parameter is plotted against 
the stimulation in full-length RNA for ElA, Tat, or Tat + ElA. 
The data are from Figs. 1 and 2C. 
Synergy is not due to increased transcriptional 
initiation 
To pursue further the mechanism underlying the syn-
ergy between Tat and ElA on RNA accumulation, we 
studied their combined effects on HIV-1-promoted tran-
scription rates by nuclear run-on analysis (Greenberg 
and Ziff 1984). Nuclei were isolated from recombinant 
adenovirus-infected cells, and nascent transcripts were 
pulse-labeled with [a-'^^PjUTP. The RNA was isolated 
and hybridized to short single-stranded DNA probes cor-
responding to the HIV-1 leader (fragment I) and to the 5' 
end of the CAT gene (fragments II and III; Fig. 4B). Under 
these conditions, the amount of radioactivity hybri-
dizing to each antisense (-i-) probe is a measure of the 
relative transcription rate in that region of the gene and 
provides an estimate of RNA polymerase distribution 
(Laspia et al. 1989). 
In the absence of trans-activators, as we found earlier, 
transcription was low in the promoter proximal region 
(fragment I) and decreased markedly in the CAT se-
quences (fragments II and III) (Fig. 4A, HeLa). Both Tat 
and ElA increased transcription in fragment I (Fig. 4A), 
as well as a subfragment of I, fragment lA, which corre-
spond to the first 24 nucleotides of the HIV-1 leader (Fig. 
4C). This suggests that both Tat and ElA increase RNA 
polymerase density in the immediate vicinity of the pro-
moter, consistent with them both acting to increase 
transcriptional initiation (Laspia et al. 1989). Although 
the formal possibility exists that Tat might overcome a 
block to elongation within the first several nucleotides, 
giving the appearance of an increase in initiation, no evi-
dence exists to support this. Indeed, were there a com-
plete block to elongation near the transcription start site 
we would not expect ElA to increase promoter proximal 
transcription. 
As shown earlier. Tat also suppressed the polar effect 
on transcription in the CAT sequences, whereas EI A did 
not. Unexpectedly, simultaneous expression of Tat and 
ElA did not elicit any obvious increase in transcription 
in fragment I relative to either Tat or ElA alone, al-
though quantitation of subsequent experiments revealed 
a nearly additive effect (see below). Furthermore, 
Tat -I- ElA did not produce a greater-than-additive in-
crease in transcription rates in fragment lA (Fig. 4C). 
Our inability to observe a synergistic increase in pro-
moter proximal transcription was not due to saturation 
of the DNA probes bound to the filters, as a threefold 
dilution of the labeled nascent RNA was reflected in a 
threefold decrease in signal (Fig. 4C). Therefore, in-
creased initiation cannot account for the synergy pro-
duced by Tat -t- ElA on HIV-1-directed RNA levels. 
In the adjacent region of the CAT gene (fragments II 
and III), Tat -I- ElA again did not elicit any obvious in-
crease in transcription rates over Tat alone (Fig. 4), so 
synergy also carmot be explained by a suppression of 
transcriptional polarity that can be detected over the 
first 333 nucleotides of the LTR-promoted CAT tran-
scription unit. However, Tat -I- ElA produced an in-
crease over ElA alone, indicating that when transcrip-
tional initiation is elevated by ElA, Tat suppresses tran-
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Figure 4. Analysis of HIV-1 transcription by nuclear run-on assay. 
[A] Nuclear run-on transcription assays of HeLa cells (HeLa), 
HeLa/fflt cells ( + tat], HeLa cells coinfected with dl309 (-l-ElA), or 
HeLa/£flf cells coinfected with di309 { + tat +E1A), all infected 
with HIV-ICATad. Infections were carried out as in Fig. I, and 
nuclei were isolated at 24 hr postinfection. Nuclear run-on assays 
were carried out for 5 min, and RNA was hybridized to filters con-
taining antisense | +) or sense ( - ) MIS single-stranded DNA 
probes. Transcription of p-actin was measured to control for the 
recovery of nascent transcripts. Autoradiographs were exposed for 
different times to obtain similar signals for p-actin. [B] Schematic 
of the DNA probes used in the nuclear run-on assay. [Top] The 
region of HIV-1 in the recombinant adenovirus HIV-ICATad; 
[second line] a restriction map of the HIV-1 LTR CAT gene fusion 
in this virus; [third and fourth hnes) fragments cloned into MIS 
and used as single-stranded probes for the nuclear run-on assay. Fragment US extends from - IS5 to - 19; fragment I extends from 
- 18 to -H 83; fragment lA from - 18 to -I- 24; fragment IB from + 21 to -i- 83; fragment II from -f- 78 to -I- 228; fragment III from -I- 229 to 
-I-333. [Bottom] The uridine contents of the RNA fragments corresponding to probes 1, II, and III. (C) Nuclear run-on transcription 
assays of HeLa cells (HeLa), HeLa/tat cells i + tat], HeLa cells infected with di309 (-i-EIA), or HeLa/tat cells coinfected with £iiS09 
{ + tat -l-EIA) that were infected with HIV-ICATad. Infections and nuclear run-on assays were performed as in Fig. 4A except that 
hybridizations and washes were performed at 59°C rather than 65°C. The sense ( - ) control for fragments lA and IB was fragment I. 
The higher background hybridization to sense ( - ) p-actin was due to the lower hybridization temperature. 
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scriptional polarity in fragments II and III just as it does 
in the absence of El A. Therefore, when the level of tran-
scriptional initiation is elevated (by ElA in this case), 
the primary effect of Tat is to increase elongation: This 
may afford an explanation for the lack of an effect of Tat 
on initiation in some systems (Kao et al. 1987). In sum-
mary, the data of Figure 4 can account for the stimula-
tion in full-length cytoplasmic transcripts by Tat + ElA 
compared to ElA alone (Fig. 2A), but the stimulation by 
Tat + ElA relative to Tat alone still remained to be ex-
plained. 
Relative contributions of initiation and elongation to 
trans-activation 
The observation that transcriptional synergy could not 
be explained by increased transcription initiation or by a 
detectable suppression of polarity in the promoter prox-
imal region was puzzling. A possible explanation for this 
lay in the ability of Tat to stabilize transcribing RNA 
polymerases, and we wondered whether synergy might 
become evident with greater distance from the pro-
moter. To address this possibility, we generated addi-
tional single-stranded DNA probes corresponding to the 
promoter distal region by cloning the remainder of the 
HIV-1-promoted transcription unit into Ml3 bacterio-
phages. Fragment IV (4-328 to -f633) and fragment V 
(-1-630 to +866) contain the 3' part of the CAT gene, 
whereas fragment VI (-I- 867 to -f-1476) and fragment VII 
(-1-1477 to +1714) contain the SV40 small t intron and 
polyadenylation signal, respectively (Fig. 5B). These ad-
ditional probes allowed us to measure the relative tran-
scription rates across the entire HIV-1 LTR-directed 
transcription unit and permitted estimation of the con-
tributions of initiation and elongation to tr^iis-activa-
tion. The relative increase in transcription rate in the 3' 
end of the transcription unit is a measure of the stimula-
tion of overall transcription of the gene and reflects the 
maximum potential contribution of transcription to in-
creased gene expression. Transcription rates in the 3' 
end of the gene were approximated in fragment VI be-
cause the signal of fragment VII in HeLa cells was too 
low to be quantitated. The relative contribution of elon-
gation was calculated by dividing the increase in overall 
transcription (fragment VI) by the increase in initiation 
(fragment I). 
Figure 5A shows an autoradiogram of a nuclear run-on 
assay using contiguous probes that extend across the en-
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Figure 5. Measurement of transcription rates through-
out the entire HIV-1-promoted transcription unit. [A] 
Nuclear run-on assays of HeLa cells (HeLa), HeLa/faf 
cells ( + tat), HeLa cells coinfected with di309 (+ ElA) or | 
HeLa/tat cells coinfected with dl309 { + tat -f- EI A) cells °^ 
that were infected with HIV-lCATad. Assays were car- § 
ried out as in Fig. 4A. {B] Schematic of DNA probes used a 
in the nuclear run assay. Fragments I, II, III, and p-actin ^ 
are described in Fig. 4B. Fragment IV extends from -t-328 | 
to -f 633; fragment V from -(-630 to -1-866; fragment VI "^  
from 4-867 to -f 1476; fragment VII from +1477 to | 
-1-1717. (C) Relative transcription rate throughout the i 
HIV-1-promoted transcription unit. Nuclear run-on a 
assays were quantified by direct scanning of the nitrocel-
lulose filters. Radioactivity was normalized for the un-
dine content of each transcript and to the p-actin signal. 
The transcription rate for each fragment relative to tran-
scription in fragment I in HeLa cells is plotted against 
the distance from the promoter midway through each 
fragment. Data are averages of four assays. 
tire HIV-1-directed transcription unit. Table 1 displays 
quantitation of the relative transcription rate in each 
fragment for this experiment, after standardization to 
the p-actin radioactive signal and normalization for the 
uridine content of each RNA fragment. The relative 
transcription rates from several experiments are aver-
aged and plotted in Figure 5C. 
In the absence of trans-activator (Fig. 5A, HeLa), po-
larity reduced transcription in the 3 ' region (fragment 
VI) to < 5 % of that in the promoter proximal region 
(fragment I, Table 1). The distribution of polymerases 
traversing the entire transcription unit revealed an ini-
tial sharp decline in polymerase density in the first 300 
nucleotides, followed by a continued decline at a lesser 
rate (Fig. 5C). 
Tat increased promoter proximal transcription nine-
fold (fragment I) (Fig. 5A; Table 1). In addition, Tat sup-
+Tat +E1A 
+E1A , if additive) 
200 600 800 1000 1200 
Distance From Promoter (nt) 
1400 1600 
pressed polarity such that 40% of the initiating RNA 
polymerases transcribed into fragment VI. With Tat, the 
density of transcribing RNA polymerases initially de-
clined in the 5' end of the gene (fragments II and III), 
although less sharply than in the absence of tr^ans-acti-
vators; polymerase density remained level in the 3' part 
of the gene, unlike in the absence of trazis-activators. 
The net result was a larger increase in transcription rates 
in the promoter distal fragment VI than could be de-
tected in fragments I, II, and III. The increase in overall 
transcription rates in fragment VI by Tat was 80-fold; 
therefore, Tat stimulated transcription rates 9-fold due 
to its ability to stabilize elongation and 9-fold due to its 
ability to stimulate initiation. 
ElA produced a fourfold stimulation in promoter 
proximal transcription (fragment I) and a smaller, but re-
producible, stimulation of elongation, such that 13% of 
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Table 1. Relative transcription rates in the HIV-1 LTR-directed CAT transcription unit 
Relative transcription*" 
Fragment HeLa + Tat + E1A + Tat + El A 
I 
II 
III 
IV 
V 
V 
VII 
I.O 
0.19 
0.11 
0.09 
0.10 
0.046 
9.3(1.0) 
3.9 (0.42) 
3.5 (0.38) 
5.7 (0.62) 
4.6 (0.50) 
3.7(0.40) 
2.5(0.27) 
4.0 (1.0) 
1.0 (0.25) 
0.68(0.17) 
0.82 (0.20) 
0.93 (0.23) 
0.53(0.13) 
0.54(0.13) 
15.0(1.0) 
7.9 (0.53) 
6.4 (0.43) 
9.3 (0.62) 
12.8 (0.85) 
11.4(0.76) 
8.2(0.55) 
"Quantitation of nuclear run-on assay blots, normalized for transcript uridine content and to p-actin transcription rate (to correct for 
RNA recovery). 
''Transcription is expressed relative to the transcription in fragment I in HeLa cells. 
•^Numbers in parentheses refer to transcription in the fragment relative to transcription in fragment I in that column. 
•^ Signal too low to be accurately quantified. 
the initiating RNA polymerases transcribed into frag-
ment VI (compared with 5% in the absence of trans-ac-
tivators). As with Tat, after an initial decrease in frag-
ments II and III, polymerase density stabilized in distal 
regions of the gene. This led to an El A effect on elonga-
tion that was small in the promoter proximal fragments 
(fragment II and III) but detectable in the 3 ' end of the 
gene. These results suggest that in addition to increasing 
initiation, EIA is also able to exert a small stabilizmg 
influence on transcriptional elongation. 
Transcriptional synergy is due to increased promoter 
distal transcription rates 
Although the stimulation is difficult to see in the pro-
moter proximal region (fragments I, II, and III), Figure 5A 
clearly shows that Tat -h EIA elicited a greater increase 
in the transcription of the distal fragments VI and VII 
than did Tat alone. Quantitation revealed that 
Tat -f EIA produced a 15-fold increase in promoter 
proximal transcription, which is approximately equal to 
the sum of their individual effects (Table I). In addition, 
Tat + EIA dramatically suppressed polarity, leading to 
an increase in HIV-1-promoted overall transcription of 
250-fold (fragment VI). This stimulation in overall tran-
scription was much larger than could be explained if 
these two tr(3/2s-activators acted additively (Fig. 5C, 
dashed line) and is due to suppression of transcriptional 
polarity because 76% of the initiating RNA polymerases 
transcribe to the end of the gene in the presence of 
Tat + EIA, whereas only 40% do so with Tat alone. 
Thus, Tat + EIA produce an additive stimulation in 
transcription initiation, but increased elongation ac-
counts for transcriptional synergy. 
Synergy between Tat and a phorbol ester 
These findings led us to consider the interaction be-
tween Tat and other transcriptional activators that in-
fluence FiIV-1 gene expression. Phorbol I2-myristate 13-
acetate (PMA) is capable of stimulating transcription 
through activation of transcription factors such as AP-1 
and NF-KB that interact with common upstream pro-
moter elements (Sen and Baltimore 1986; Angel et al. 
1987). Tat and PMA have been shown to stimulate 
HIV-1 LTR-directed CAT expression synergistically 
(Nabel and Baltimore 1987; Siekevitz et al. 1987; Tong-
Starksen et al. 1987). 
Analysis of the effect of Tat and PMA on LTR-directed 
cytoplasmic RNA levels is shown in Figure 6. Tat pro-
duced a 13-fold stimulation in full-length RNA (Fig. 6A, 
lane 2; Fig. 6B). Like EIA, PMA increased the level of 
both the full-length and the short transcripts suggesting 
that it stimulates transcriptional initiation. However, 
the 2.3-fold stimulatory effect of PMA on the level of the 
full-length transcripts (Fig. 6A, lane 3; Fig. 6B) was 
smaller than the 4-fold effect produced by EIA, while 
the short transcripts appeared to be increased to a greater 
extent (Fig. 2C). Tat + PMA produced a 141-fold stimu-
lation in the levels of full-length RNA (Fig. 6A, lane 4; 
Fig. 6B), which was greater than if they acted additively. 
Similar results were obtained when the cells were 
treated with PMA for 4 hr (as shown) or 16 hr (data not 
shown). Thus, PMA cooperates with Tat to elevate 
HIV-1-promoted RNA levels synergistically. As with 
EIA, the level of the short transcripts with Tat + PMA 
was the same as with PMA alone but higher than with 
Tat alone. These findings indicate that synergy between 
Tat and PMA may operate through a mechanism similar 
to that between Tat and EIA. 
Discussion 
Transcription of HIV-1 genes is regulated by at least two 
types of trans-activators. One class of activator interacts 
with upstream cis-regulatory DNA elements to increase 
transcriptional initiation. These activators include 
NF-KB, which interacts with the core enhancer (Nabel 
and Baltimore 1987); Spl, which has binding sites up-
stream of the HIV-1 promoter (Jones et al. 1986); and the 
adenovirus EIA protein, which interacts with the TATA 
element (Jones et al. 1988; Nabel et al. 1988; Rice and 
Mathews 1988b). The second class of activator consists 
of the HIV-1 Tat protein and its homologs from HIV-2 
and SIV, which bind to a cis-regulatory RNA element, 
TAR, in nascent transcripts. Tat can act both to increase 
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Figure 6. Synergy between Tat and PMA. [A] RNase protec-
tion assay of cytoplasmic RNA isolated from HIV-lCATad-m-
fected HeLa cells (lane 1], HeLa/tat cells (lane 2), and HeLa cells 
or Hela/tat cells treated with 200 ng/ml PMA (lanes 3 and 4). 
Markers are Hpall fragments of pBR322 labeled with ^^P. 
HrV-lCATad infections were carried out at an moi of 100, and 
PMA treatment was at 20 hr postinfection. Cytoplasmic RNA 
was isolated at 24 hr postinfection and analyzed as in Fig. 2A. 
Similar results were obtained when PMA was added 8 hr post-
infection and RNA was isolated 24 hr postinfection (data not 
shown). (B) Relative HIV-1-directed RNA levels. The stimulation 
in full-length transcripts relative to HeLa cells was quantified as 
in Fig. 2C. 
transcriptional initiation and stabilize elongation (La-
spia et al. 1989). Cooperation between the two classes of 
trans-activator produces a synergistic stimulation of 
HIV-1 LTR-directed gene expression (Nabel and Balti-
more 1987; Tong-Starksen et al. 1987; Rice and 
Mathews 1988b). 
To discover the molecular basis for this synergy, we 
examined the combined effects of Tat and El A on 
HIV-1-directed RNA levels and transcription rates. Syn-
ergy between Tat and El A was accounted for by a stimu-
lation of RNA levels that resulted from an increased rate 
of LTR-directed transcription. With other cellular pro-
moters, heterologous acidic activators have been shown 
to stimulate transcription synergistically, possibly by 
cooperatively increasing the binding of an essential 
target molecule (Lin et al. 1990). Surprisingly, synergy 
between Tat and El A, elucidated by an analysis of RNA 
polymerase density across the HIV-1-promoted tran-
scription unit, was not caused by increased transcrip-
tional initiation: The combined effect of Tat and El A on 
initiation was only additive. Rather, synergy resulted 
from stimulation of transcriptional elongation. This 
novel form of cooperation may not be unusual in view of 
the finding that Tat and the general transcriptional acti-
vator PMA exhibited a pattern of regulation of cyto-
plasmic RNA levels similar to that of Tat -f ElA. 
Clearly the effect of Tat on initiation is variable in 
magnitude. In the presence of El A, Tat stimulated initi-
ation to a lesser extent than it stimulated the basal level 
of initiation from the HIV-1 promoter. The reduced sen-
sitivity is attributable to saturation of the initiation ma-
chinery, perhaps because of limiting transcription factor 
concentrations or steric hindrance at the promoter. Sim-
ilarly, it is likely that elevated basal HIV-1 transcription 
in the transfected COS cell system may explain why Kao 
et al. (1987) observed a stimulatory effect on elongation 
but not initiation (M. Kessler and M.B. Mathews, in 
prep.). This observation could have implications for the 
development of systems that seek to analyze the stimu-
lation of transcription by Tat in vitro because the mag-
nitude of the initiation effect may be strongly influenced 
by the strength of the promoter. As shown recently, Tat 
stimulates transcription in vitro with the primary effect 
being at the level of elongation (Marciniak et al. 1990). 
How is synergy between Tat and ElA achieved at the 
molecular level? One possible explanation proposes that 
Tat stabilizes the elongation of the additional initiation 
complexes (those whose presence on the template is due 
to ElA) in the same way and to the same extent as it 
stabilizes elongation of complexes formed in the absence 
of ElA. However, this explanation is insufficient to ac-
count for the degree of suppression of polarity seen, be-
cause 75% of initiation complexes reach the 3 ' end of 
the gene with Tat -f- ElA versus 40% with Tat alone 
and only 13% with ElA alone. It seems that the coopera-
tive effect on stabilization of elongation may stem from 
the formation of transcriptional complexes in the pres-
ence of both trfl/25-activators that are capable of more 
efficient elongation than those formed with either 
trans-activatoi alone (Fig. 7). A third possibility, sug-
gested by the finding that ElA also appears to suppress 
polarity to some extent, is that increasing RNA poly-
merase density on the template stabilizes elongation, 
perhaps by altering chromosome structure or conforma-
tion. 
It is clear from these and other studies (Kao et al. 
1987; Laspia et al. 1989; Ratnasabapathy et al. 1990) that 
Tat makes a major contribution to transcriptional elon-
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Figure 7, Model for synergy between Tat and EIA. In the ab-
sence of trans-activators, transcriptional initiation is low and 
elongation is unstable. Tat increases transcriptional initiation 
and stabilizes elongation. EIA increases initiation and has a 
small stabilizing effect on elongation. Tat and EIA cooperate to 
promote the formation of a highly processive RNA polymerase 
complex resulting in a synergistic increase in polymerase den-
sity in the 3' end of the transcription unit with only an additive 
effect on initiation. 
gation. In some of the experiments shown here (Fig. 5), 
increased elongation appears to accompany increased 
initiation, suggesting that elongation may be aided by 
increasing rates of initiation. However, the effect of Tat 
on elongation is a specific one because under conditions 
where Tat and EIA produce similar increases in initia-
tion Tat always suppresses polarity to a greater extent 
than EIA (Fig. 4A,C; Laspia et al. 1989). Peterlm and col-
leagues proposed that Tat acts as an antiterminator, per-
mitting readthrough of transcription complexes blocked 
in the TAR region (Kao et al. 1987; Selby et al. 1989). We 
find that most transcription termination occurs in the 
first 400 nucleotides of the HIV-1-directed transcription 
unit. Rather than acting to relieve a block to transcrip-
tion at a specific terminator site, as occurs at nut sites in 
the leftward promoter of bacteriophage A. (Roberts 1988), 
we favor the idea that Tat stimulates elongation through 
a number of critical regions in the HIV-1 leader and the 
CAT sequences where pausing or termination occurs 
(M. Kessler and M.B. Mathews, in prep.). Thus, the short 
RNAs whose 3 ' ends map to the base of the s tem-loop 
formed by the HIV-1 leader RNA may be formed by the 
processing of longer, but incomplete, transcripts pro-
duced by termination or pausing downstream. This idea 
is supported by analysis of the short HIV RNAs gener-
ated in vitro (Toohey and Jones 1989). 
Elongational instability is likely to be specified at the 
promoter through an interaction at the DNA level be-
cause mutations that abolish the structure of TAR RNA 
do not relieve polarity (Laspia et al. 1989). It appears that 
delivery of Tat to the HIV-1 promoter is sufficient to in-
crease LTR-directed transcription rates (Southgate et al. 
1990). Tat may exert its influence on HIV-1 transcrip-
tion by contacting RNA polymerase or transcription 
factors such as TFIID directly or, alternatively, by acting 
through upstream activators such as Spl and NF-KB. In 
support of this theory, Spl deletion mutants show re-
duced stimulation of HIV-1 RNA levels by Tat but not 
by EIA (M. Laspia, unpubl.). As a unifying hypothesis, 
we propose that Tat mediates the formation of an initia-
tion complex containing certain constellations of up-
stream factors and facilitates the stable binding of elon-
gation factors. Alternatively, Tat may act as an elonga-
tion factor itself or work through other elongation 
factor(s) that interact with the postinitiation RNA poly-
merase and thereby promote stable elongation. 
Synergy between Tat and general transcriptional acti-
vators has potential implications for the regulation of 
HlV-1 gene expression. Early in infection or during viral 
latency, the HIV-1 LTR is relatively inactive, possibly 
because levels of Tat protein are rate limiting. Stimula-
tion by antigen or cytokines induces the LTR to become 
transcriptionally active due to the induction or activa-
tion of cellular transcription factors (Cullen and Greene 
1989; Pomerantz et al. 1990). Because of transcriptional 
polarity, most of the RNA polymerases that initiate 
transcription terminate prematurely. However, once Tat 
has accumulated, it may act in concert with activated 
transcription factors in the cell to cause a large increase 
in gene expression. This burst of transcriptional activity 
may serve as a molecular trigger that induces HIV-1 to 
transit from latency to active viral growth. 
During our analysis of the basis for synergy, we no-
ticed a discrepancy between the relative increase in re-
porter enzyme activity and reporter RNA levels. Similar 
discrepancies have been reported previously and 
ascribed to post-transcriptional regulation by Tat 
(Cullen 1986; Feinberg et al. 1986; Rosen et al. 1986; 
Wright et al. 1986). Recent studies have provided com-
pelling evidence for a translational regulation by Tat in 
Xenopus oocytes (Braddock et al. 1989, 1990). Other 
workers, however, have failed to observe a post-tran-
scriptional effect (Peterlin et al. 1986; Jeang et al. 1988; 
Rice and Mathews 1988a). In the experiments described 
here, we found that both EIA and Tat increased the uti-
lization of TAR-CAT RNA and that a correlation exists 
between the level of cytoplasmic CAT RNA and the ef-
ficiency with which it was utilized to produce CAT en-
zyme. It is therefore possible that the apparent post-
transcriptional effect of Tat is seen only in systems pos-
sessing low basal levels of HIV-1 expression. Moreover, 
the finding that two different trans-activators increased 
T A R - C A T RNA utilization suggests that the effect is a 
function of increased mRNA level and not a specific ac-
tion of Tat. The alternative, that EIA and Tat might 
both act specifically to increase translation of the T A R -
CAT RNA, is, in our view, much less likely. 
In conclusion, our findings provide an explanation for 
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the synergistic stimulation of HIV-1 gene expression 
produced by Tat and general transcriptional activators. 
Furthermore, they underscore the importance of the 
ability of Tat to stabilize transcriptional elongation, in 
conjunction with its ability to stimulate initiation, in 
the regulation of HIV-1 transcription. In addition, we 
provide a possible explanation for the variable magni-
tude of the Tat/TAR effect on transcriptional initiation. 
We propose that Tat and general transcription activators 
can cooperate to cause the formation at the HIV-1 pro-
moter of an initiation complex capable of very stable 
transcriptional elongation. 
riboprobe was synthesized from Unearized pGEM23 vectors, 
and the RNase protection assay was performed as described 
(Laspia et al. 1989). Briefly, 5 [xg of RNA and 1 x 10* cpm of 
riboprobe in 30 p.! hybridization buffer were denatured and in-
cubated overnight at 40°C. The mixture was then digested with 
10 ^g/ml RNase A and 10 J^Lg/ml RNase Tl in 300 |xl of diges-
tion buffer at room temperature. RNase digestion products 
were separated by electrophoresis in 8% polyacrylamide-7 M 
urea sequencing gels. Controls were performed to show that 
assay was in the linear range. Protected fragments were visual-
ized by autoradiography with an intensifying screen and quan-
tified by direct scanning of dried gels with a Betagen radioana-
lytic imaging system. 
Materials and methods 
Adenoviruses, cell cultures, and infections 
HIV-lCATad contains HIV-1 sequences - 642 to + 83 (Rice and 
Mathews 1988a,b). ElA was supplied by infection with the 
phenotypically wild-type adenovirus 5 dl309 (Jones and Shenk 
1979). 
HeLa cells and HeLa/tat cells were kindly provided by K. Va-
lerie (Smith, Kline and French Laboratories; Valerie et al. 1988). 
HeLa cells were grown in Dulbecco's modified medium supple-
mented with 10% fetal bovine serum, and HtLa/tat cells were 
maintained in medium containing 200 |xg/ml geneticin. 
Approximately 7.5 x 10* cells in 10-cm dishes were infected 
at 37°C with a recombinant adenovirus in Dulbecco's modified 
medium supplemented with 2% gamma-globulin-free serum 
(Laspia et al. 1989). At 2 hr postinfection the medium was re-
placed with fresh medium containing 10 mM hydroxyurea to 
prevent recombinant adenovirus replication, especially in the 
case of coinfection with dl309. Cells were washed in phos-
phate-buffered saline (PBS) and harvested by scraping in PBS. 
Plasmid construction 
Antisense (-f) and sense ( - ) single-stranded DNA probes used 
in the nuclear run-on assay were M13 clones containing HIV-1 
LTR sequences derived from pU3RIlI (Sodroski et al. 1985a). 
Construction of probes U3, \, lA, IB, II, III, and p-actin have 
been described (Laspia et al. 1989). Additional M13 probes con-
structed for this study are probe IV -1-328 (£coRI) to -1-633 
(Ncol); probe V -1-639 to +866 [Sau3K]; probe VI -h867 to 
+ 1476 (Sau3A); and probe VIII + 1477 (Bc7l) to + 1717 (BflmHI). 
Probe VI corresponds to SV40 sequences 4713-4104, and probe 
VII to sequences 2770-2553. 
CAT assays 
Cells from one 10-cm plate were harvested and resuspended in 
0.25 M Tris (pH 8.0) and lysed by three freeze/thaw cycles. Ly-
sates (50 jxl), from one-sixth of a plate, were assayed for CAT 
activity as described (Gorman et al. 1982). Thin-layer chro-
matograms were quantified with an Ambis Betascan System 
(San Diego, CA). CAT activity is presented in terms of units 
where 1 unit is defined as the conversion of 1 % chloramphen-
icol to the acetylated form in a 1-hr reaction at 37°C. Extracts 
with high activity were diluted or incubated for shorter times 
so that <50% of the substrate was acetylated, ensuring that the 
assay was in the linear range. 
RNA isolation and RNase protection assay 
Cytoplasmic RNA was prepared following lysis with Nonidet 
P-40 as described (Anderson et al. 1974). Homologous antisense 
Nuclear run-on transcription assay 
Recombinant adenovirus-infected cells were harvested at 24 hr 
postinfection, and nuclei were prepared and stored in liquid ni-
trogen. Isolation of nuclei and nuclear run-on assays were per-
formed as described by Greenberg and Ziff (1984), with minor 
modifications (Laspia et al. 1989). Briefly, 3 x 10'' nuclei were 
thawed, mixed with an equal volume of twofold concentrated 
transcription buffer containing 200 jxCi (a-^^PjUTP (3000 
Ci/mM), and incubated for 5 min at 30°C. Reactions were 
stopped by the addition of 0.6 ml of 10 mM Tris (pH 7.4), 50 mM 
MgCli, 2 mM CaCli, 500 mM NaCl, 40 (xg/ml oi DNase I, and 
3.3 i^.g/ml a-amanitin. RNA was isolated, fragmented with 0.2 
N NaOH for 15 min on ice, and neutralized with HEPES buffer. 
M13 DNA probes (5 (xg) were attached to nitrocellulose filters 
using a slot blot apparatus. RNA hybridization and RNase 
treatment of the filters were performed as described (Greenberg 
and Ziff 1984). Filters were subjected to autoradiography with 
an intensifying screen. Bound radioactivity was quantified with 
a Betagen radioanalytic imaging system. 
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